Dr. B

What Dr. B does

Dr. B, PBC is a US telehealth company founded in 2020–2021 by Cyrus Massoumi and headquartered in New York. It operates a direct-to-consumer platform, accessible via website and mobile app, that delivers AI-assisted online medical consultations reviewed and authorized by licensed physicians and nurse practitioners across all 50 states on a 24/7 basis. Standard consultations are priced at $19 with no insurance required, and prescriptions are routed to the patient's chosen retail pharmacy among Walmart, Walgreens, Target, CVS, and Costco.

The platform's service surface spans four treatment categories: Primary Care (UTIs, allergies, hypertension, flu, and other common conditions), Dermatology (hair loss, eczema, rosacea, and similar), Sexual and Reproductive Health (birth control, ED, herpes), and a Longevity vertical that includes the Shed It medical weight loss program with GLP-1 medications, Optimize It hormone replacement therapy, and HSA/FSA-eligible fitness, nutrition, and rehabilitation programs. Underlying technology combines a text-based AI consultation intake with provider review and a pharmacy routing layer that displays medication price comparisons across local and online pharmacies. A No-Cost Care program funded by a portion of paid consultations has delivered over 25,000 free visits to qualifying patients.

The business model is primarily transactional, with $19 per-consultation unit pricing for acute care, supplemented by higher-priced monthly Longevity subscriptions. Distribution is product-led and self-serve, with no enterprise channel; growth relies on direct website traffic, social media presence, and earned media coverage. The company is structured as a Delaware Public Benefit Corporation, is a Certified B Corporation and LegitScript-approved, and has raised a single disclosed $8 million seed round in August 2022 from Lerer Hippeau, Founders Fund, LeFrak, Life Extension Ventures, and Pareto Holdings.

Name

Dr. B

Legal name

Dr. B, PBC

Website

https://hidrb.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Dr. B is a US telehealth platform offering AI-assisted online medical consultations reviewed by licensed providers, starting at $19 without insurance, and delivering prescriptions to major retail pharmacies for 30+ conditions including primary care, dermatology, sexual health, and longevity programs.

Ownership category

akta.pro rank

Product category

Telehealth Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Primary Care & General Medicine Virtual Care (HLALAAAA)

akta.pro secondary industries

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ)

Keywords

• Telehealth consultations
• Online medical care
• Prescription medications
• Medical weight loss
• Affordable healthcare

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Consultation Fees: Dr. B charges $19 for most standard online medical consultations. Longevity programs cost more with pricing displayed on treatment pages. Revenue is generated on a per-consultation basis with no subscription requirement.
2. No-Cost Care Program: Free consultations provided to patients who qualify due to financial hardship, funded by a portion of paid consultations. Over 25,000 No-Cost Care consultations have been given to date.
3. Prescription Medications: Patients pay for prescribed medications at their chosen pharmacy. Dr. B displays medication costs at local and online pharmacies so patients can view lowest-cost options and offers drug discount cards.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Dr. B is a direct-to-consumer telehealth platform that provides affordable online medical consultations starting at $19, where patients complete AI-powered intake that is reviewed by state-licensed doctors and nurse practitioners. Prescriptions for 30+ conditions across Primary Care, Dermatology, Sexual + Reproductive Health, and Longevity (including GLP-1-based weight loss and hormone therapy) are routed to the patient's chosen pharmacy, with a No-Cost Care program subsidizing free consultations for financially qualifying patients.

Product overview

Dr. B is a unified telehealth platform offering AI-assisted online medical consultations with licensed providers across the United States. The platform provides prescription medications for over 30+ conditions organized into four main treatment areas: Primary Care (common conditions like UTIs, allergies, flu), Dermatology (skin and hair conditions), Sexual + Reproductive Health, and Longevity programs. The Longevity suite includes Shed It (medical weight loss with GLP-1 medications), Optimize It (hormone therapy for women), and HSA/FSA-eligible fitness, nutrition, and rehabilitation programs. The platform also offers No-Cost Care for financially qualifying patients. Originally launched in August 2022 focusing on COVID-19 antivirals (Paxlovid and molnupiravir), Dr. B has expanded to become a comprehensive affordable telehealth service starting at $19 per consultation with no insurance required.

Differentiator

Problem solved

Functional benefit

Products and services

• Dr. B Telehealth Platform A telehealth platform offering AI-assisted online medical consultations reviewed by licensed doctors and nurse practitioners across the United States, providing affordable prescription medications for 30+ conditions without requiring insurance or in-person visits.
• Primary Care

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability2 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Paxlovid (Pfizer)coreOthersDr. B initially launched with focus on COVID-19 antiviral treatments, offering Paxlovid and molnupiravir. These medications are provided through prescriptions sent to patient-chosen pharmacies.
• Molnupiravir (Merck)coreOthersDr. B initially launched with focus on COVID-19 antiviral treatments, offering molnupiravir alongside Paxlovid. These medications are provided through prescriptions sent to patient-chosen pharmacies.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Curology: DTC telehealth brand specializing in prescription dermatology (acne, anti-aging, hyperpigmentation) with a custom-formulation model — directly comparable to Dr. B's dermatology offering but with deeper specialty focus.

Direct peers

• Nurx: Direct-to-consumer telehealth company focused on sexual and reproductive health (birth control, STI testing, HPV) with prescription delivery — overlaps significantly with Dr. B's Sexual + Reproductive Health vertical.
• Lemonaid Health: Telehealth platform offering low-cost online consultations and prescriptions for primary care, mental health, and reproductive health — closely mirrors Dr. B's $19-style pricing and condition-specific Rx model.
• GoodRx: Public consumer healthcare platform combining prescription discount cards with telehealth consultations (GoodRx Care) — directly comparable cash-pay model and emphasis on affordable medication access for uninsured patients.
• Ro: Direct-to-consumer telehealth company offering cash-pay treatments across weight loss (GLP-1s via Ro Body), ED, hair, fertility, and primary care — closest product-by-product overlap with Dr. B's Primary Care, Sexual + Reproductive Health, and Shed It offerings.
• K Health: AI-driven primary care telehealth platform offering 24/7 consultations and prescriptions; competes head-on with Dr. B's AI-consult-with-provider-review architecture and primary-care-first positioning.
• Hims & Hers Health: Public direct-to-consumer telehealth platform offering cash-pay prescription treatments for hair loss, ED, weight loss (GLP-1s), primary care, and dermatology — the most direct large-scale comparable to Dr. B's catalog and cash-pay model.

Broad incumbents

• MDLive (Evernorth/Cigna): Established telehealth platform owned by Cigna's Evernorth, providing primary care, behavioral health, and dermatology — a broad incumbent competing for the same patient demand, primarily via insurance rather than cash pay.
• Teladoc Health: Large incumbent virtual care provider offering primary care, mental health, and specialty telehealth to insurers and employers — operates at greater scale and through payer channels rather than Dr. B's direct cash-pay model.

Others

• Walmart Health (telehealth and pharmacy services): Walmart operates one of Dr. B's pharmacy distribution partners and has piloted its own low-cost telehealth and primary care services — represents both a fulfillment partner and a potential vertical integrator threat.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/drbisin
• Facebookfacebook.com/drbisin
• LinkedInlinkedin.com/company/hidrb
• Instagraminstagram.com/drbisin

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr. B